Release Date: 10/11/11 09:33 Summary: Daily share buy-back notice - Appendix 3E Price Sensitive: No Download Document 87.26KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%